Treatment of pervasive developmental disorders with redox-active therapeutics
AssigneeEdison Pharmaceuticals, Inc.
InventorsGuy M. Miller, Viktoria Kheifets
Life of this patent
Estimating the term…
Abstract
Methods of treating or suppressing pervasive developmental disorders (PDDs) including; autistic disorder, Asperger's syndrome, childhood disintegrative disorder (CDD), Rett's disorder, and PDD-not otherwise specified (PDD-NOS) or attention deficit/hyperactivity disorder (ADHD) comprising administering to a subject in need thereof a therapeutically effective amount of one or more compounds as disclosed herein.
Claims31
A method of reducing the symptoms associated with, or for treating or suppressing a pervasive developmental disorder (PDD) or attention deficit/hyperactivity disorder (ADHD) in a patient in need of such treatment, comprising administering to the patient a therapeutically or physiologically effective amount of a compound of Formula V,
- wherein:
- R1, R2, and R3 are independently selected from the group consisting of H, (C1-C6)alkyl, (C1-C6)haloalkyl, (C1-C6)alkoxy, halogen and CN;
- or a stereoisomer, a mixture of stereoisomers, a solvate or a hydrate thereof.
Dependencies are inferred from the claim text.